Literature DB >> 12465395

Asian trends in prostate cancer hormone therapy.

Hideyuki Akaza1, Seiji Naito, Christopher Cheng, Amir Kaisary, Doddy M Soebadi, Rainy Umbas, Kesavan Esuvaranathan, Fang-Liu Gu, Liqun Zhou, Sung-Joon Hong, Wun-Jae Kim, Sang Eun Lee, Joung-Sik Rim, Jae Mann Song, Jin Han Yoon, Shu-Jen Chang, Chun-Hsiung Huang, Chi-Rei Yang, Yoshihiko Hirao, Masaru Murai, Taiji Tsukamoto, Michiyuki Usami.   

Abstract

The first Conference on Asian Trends in Prostate Cancer Hormone Therapy was held in September 2001 to serve as a forum for Asian urologists to compare data on prostate cancer and discuss issues regarding the use of hormone therapy. The conference revealed that due to various cultural and philosophical factors, differences exist in prostate cancer management among the Asian countries. In addition, a lack of databases on hormone therapy was exposed in some countries. It was noted that many decisions in the treatment of prostate cancer are influenced by the strategies adopted in Western countries, and that attempts to formulate uniform guidelines for the Asian region have hitherto been unsuccessful. The main findings of the conference are reported in this review.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12465395

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer.

Authors:  Jing Wu; Wei-Kang Chen; Wei Zhang; Jin-Song Zhang; Jian-He Liu; Yong-Ming Jiang; Ke-Wei Fang
Journal:  Oncotarget       Date:  2017-08-02

Review 2.  Asian trends in primary androgen depletion therapy on prostate cancer.

Authors:  Hideyuki Akaza
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.